# Module Verification Package: Post-Traumatic Stress Disorder (PTSD)
**Module Identifier:** `IMR-PTSD-2.0.0`  
**Plugin Implementation:** `PTSDPlugin` (`packages/target-engine/src/plugins/ptsd/ptsd-plugin.ts`)  
**Target Gate:** Q3 — Module Verification Qualified  
**Standard Reference:** IEC 62304:2006+AMD1:2015 §5.5 / ISO 13485:2016 §7.3.5  
**Governing Roadmap:** [`MAGNIOM-Implementation & Multi-Indication Validation Roadmap v2.0.md`](file:///home/owner/Downloads/Magniom/public/guides/MAGNIOM-Implementation%20&%20Multi-Indication%20Validation%20Roadmap%20v2.0.md) (§39, §43, §44)  
**Golden Suite Reference:** `packages/target-engine/tests/v2/golden-suites/ptsd-golden-suite.test.ts` (7 Scenarios)  
**Status:** PASS (Q3 Qualified)  
**Evaluation Date:** 2026-09-03  

---

## 1. Module Requirements Verification
- **SRS Scope:** `MAG-CLI`, `MAG-TGT`, `MAG-EVD`, `MAG-POL`.
- **Traceability:** 100% of applicable PTSD requirements traced and verified. Zero open critical defects.

---

## 2. EvidencePath Verification
- **Curated EvidencePaths:**
  - `EP-PTSD-RDLPFC-01`: Right DLPFC low-frequency (1Hz) inhibitory targeting for autonomic hyperarousal symptoms ($[42, 44, 30]$).
  - `EP-PTSD-VMPFC-02`: Ventromedial PFC fear extinction circuit hypothesis (Research only).
- **Prohibited Inheritance Invariant (§39 PTSD04):** PTSD cannot inherit left DLPFC high-frequency protocols from MDD without explicit dual-diagnosis comorbidity context.

---

## 3. Generator Verification
- **Generators:**
  - `ptsd-right-dlpfc-generator`: Nominates right DLPFC coordinates.
  - `ptsd-vmfc-fear-extinction-generator`: Exploratory fear-extinction targets in Research Mode.

---

## 4. Measurement Compatibility Verification
- **Applicability Scope:** Civilian vs. combat-related PTSD population distinction checked in clinical context.
- **Dissociative Subtype Caution:** Presence of dissociative depersonalization/derealization triggers cautionary uncertainty flagging.

---

## 5. Ranking / Refinement Verification
- Right DLPFC allocated to Primary 1 for hyperarousal distress.
- Comorbid MDD allows structured dual-circuit candidate presentation (Left DLPFC + Right DLPFC).

---

## 6. Geometry Verification
- **Permitted Geometry:** `stereotaxic_point`.
- **Laterality Invariant:** High-frequency facilitatory left DLPFC stimulation is prohibited for isolated PTSD hyperarousal.

---

## 7. Golden Case Verification (Roadmap §39)
7/7 Canonical Golden Cases PASS:
1. `PTSD-GC-01` (General Target Path): Right DLPFC 1Hz inhibitory target allocated to Primary 1. (PASS)
2. `PTSD-GC-02` (Combat Applicability Limitation): Highlights combat population limitations. (PASS)
3. `PTSD-GC-03` (Right-vs-Left Target Distinction): Clearly separates 1Hz right vs 10Hz left evidence. (PASS)
4. `PTSD-GC-04` (MDD Inheritance Prohibited): Isolated PTSD strictly blocks standard MDD priors. (PASS)
5. `PTSD-GC-05` (Research Connectome Refinement): Exploratory refinement restricted to Research. (PASS)
6. `PTSD-GC-06` (Conflicting Evidence Visible): Surfaces contradictory military RCT trials. (PASS)
7. `PTSD-GC-07` (No Valid Target): Contraindicated implant triggers clean abstention slate. (PASS)

---

## 8. Research / Clinical Boundary Verification
- **Permitted Modes:** `research` ONLY.
- **Enforcement:** Clinical signing strictly disabled (`ResearchModeSigningProhibitedError`).

---

## Formal Gate Determination
The PTSD Module satisfies all 10 Q3 Gate criteria.  
**Result: Q3 — Verification Qualified** *(Note: Q3 is not clinical validation)*.
